Sri Research For Tissue Engineering Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.18 M
as on 16-11-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 44.03%
(FY 2023)
- Ebitda 62.59%
(FY 2023)
- Net Worth -4.20%
(FY 2023)
- Total Assets -27.89%
(FY 2023)
About Sri Research For Tissue Engineering
The Corporate was formerly known as Sri Research Of Tissue Engineering Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.18 M, as per Ministry of Corporate Affairs (MCA) records.
Murali Pathai and Gowrishankar Ramachandrasastry serve as directors at the Company.
- CIN/LLPIN
U73100KA2009PTC049712
- Company No.
049712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sri Research For Tissue Engineering?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Pathai  | Director | 16-Nov-2021 | Current |
| Gowrishankar Ramachandrasastry | Director | 04-Dec-2015 | Current |
Financial Performance and Corporate Structure Insights of Sri Research For Tissue Engineering.
Sri Research For Tissue Engineering Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 44.03% increase in profit. The company's net worth dipped by a decrease of 4.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Research For Tissue Engineering?
In 2023, Sri Research For Tissue Engineering had a promoter holding of 8.41% and a public holding of 91.59%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hiten Fasteners Private LimitedActive 41 years 30 daysMurali Pathai and Gowrishankar Ramachandrasastry are mutual person
Center For Incubation Innovation Research And ConsultancyActive 8 years 2 monthsMurali Pathai and Gowrishankar Ramachandrasastry are mutual person
Cancyte Technologies Private LimitedActive 11 years 9 monthsMurali Pathai and Gowrishankar Ramachandrasastry are mutual person
- Vidya Bharathi SurakshaActive 15 years 6 months
Murali Pathai and Gowrishankar Ramachandrasastry are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Research For Tissue Engineering?
Unlock and access historical data on people associated with Sri Research For Tissue Engineering, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Research For Tissue Engineering, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Research For Tissue Engineering's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
